Welcome to our dedicated page for Kineta SEC filings (Ticker: KA), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Reading Kineta’s filings can feel like parsing a clinical protocol. Phase 1 data tables, milestone-based royalty clauses, and frequent at-the-market equity raises hide in hundreds of pages. If you are hunting for a single sentence on cash runway or the latest VISTA trial update, the raw SEC PDF is a maze.
Stock Titan ends that search frustration. Our AI breaks down every document—from a Kineta quarterly earnings report 10-Q filing to the smallest 8-K—into plain-language highlights. Want instant alerts when a director buys shares? The Kineta Form 4 insider transactions real-time feed is ready. Need the risk-factor redlines in the Kineta annual report 10-K simplified? They are one click away. Even complex 14A tables on Kineta proxy statement executive compensation are summarized so you know exactly how milestones affect bonuses.
Here is what you can do:
- Track Kineta insider trading Form 4 transactions before catalysts hit.
- Dive into Kineta earnings report filing analysis to watch R&D spend versus cash on hand.
- See every Kineta 8-K material events explained, including clinical holds or new licensing deals.
- Use our dashboards for understanding Kineta SEC documents with AI—no biostatistics degree needed.
Because our system refreshes the moment EDGAR posts, you never miss a disclosure. Whether you monitor Kineta executive stock transactions Form 4 or simply need Kineta SEC filings explained simply, the answers arrive faster than the next press release.
Kineta (KA) filed a Form 4 disclosing that director Shawn Iadonato exercised 237,500 stock options on 06/23/2025 at strike prices of $0.36 and $0.611, actions triggered by full vesting upon shareholder approval of the TuHURA Biosciences merger.
To cover taxes, 52,353 shares were sold at $0.26 (Code F). Net of the sale, his direct holdings rose to 860,377 shares; combined with 8,553 shares held via an IRA, total beneficial ownership is 868,930 shares, a ~27% increase.
The transactions were contractual (Code M) rather than open-market purchases, signalling alignment but offering limited insight into insider sentiment.
FAQ
What is the current stock price of Kineta (KA)?
What is the market cap of Kineta (KA)?
